Precision Functional Genomics
for the AI-Genomics Era
Expert PhD-led translational biology support — from genome-wide CRISPR screen design to IND-enabling assay validation and Perturb-seq datasets for AI/ML training.
What We Do Best
Deep technical expertise across the full translational biology spectrum — from target identification through clinical biomarker readiness.
CRISPR Functional Genomics
Genome-wide and targeted CRISPR knockout, activation, and interference screens in primary and transformed cell lines using pooled and arrayed formats.
Perturb-seq for AI/ML
Large-scale single-cell CRISPR perturbation datasets (Perturb-seq) designed and executed to train foundation models and support AI-driven target discovery pipelines.
ddPCR & NGS Biomarkers
Digital PCR and next-generation sequencing-based biomarker assay development, qualification, and validation — ready for IND submissions and clinical trial monitoring.
IND-Enabling Assay Development
End-to-end clinical assay development — from concept through GLP-aligned validation — generating investor-grade data packages for IND filing and regulatory strategy.
CRISPR Target Validation
Rigorous genetic target validation using CRISPR perturbation approaches in disease-relevant cell models, supporting therapeutic hypothesis testing and prioritization.
Fractional Scientific Leadership
Part-time embedded scientific leadership — serving as Fractional Chief Translational Officer to seed and Series A biotechs that need expert guidance without full-time overhead.
Built for Translational Impact
A lean, expert-first model that delivers Fortune 500 translational biology quality at a fraction of the cost of building in-house.
PhD-Led Expertise
Every project is led directly by a PhD-level scientist with hands-on experience at Cellarity, Sarepta Therapeutics, Vertex Pharmaceuticals, and Tome Biosciences — not delegated to junior staff.
Investor-Grade Documentation
GLP-aligned SOPs, electronic lab notebooks with audit trails (Benchling ELN), signed study protocols, and comprehensive final reports — data your investors and regulators will trust.
Lean & Fast
No large CRO bureaucracy. Direct scientific access, rapid project initiation, and fixed-price service packages designed to stretch seed and Series A budgets without compromising rigor.
Structured for Every Stage
Three clearly scoped service tiers — from a rapid technical audit to a full translational roadmap. Fixed pricing, milestone-based billing, and clear deliverables on every engagement.
Ready to accelerate your translational program?
From CRISPR screen design to IND-enabling assay validation — we bring the scientific depth your program needs without the full-time overhead.